Table 3.
Clinical outcomes of study patients
| Outcome (s) | Selenium group (n = 29) | Control group (n = 25) | P value |
|---|---|---|---|
| SOFA respiratory score | |||
| Day 0 | 2.3 ± 0.8 | 2.4 ± 0.8 | 0.82 |
| Day 3 | 2.5 ± 0.9 | 2.4 ± 0.9 | 0.69 |
| Day 7 | 2.1 ± 1 | 2.7 ± 1 | 0.03 |
| Day 10 | 1.6 ± 1.2 | 2.5 ± 0.8 | 0.01 |
| Day 14 | 2.2 ± 1.4 | 2.4 ± 0.9 | 0.77 |
| VAP, n (%) | 16 (55.2) | 21 (84) | 0.023 |
| Early VAP, n (%) | 15 (51.7) | 15 (60) | 0.54 |
| Late VAP, n (%) | 5 (17.2) | 11 (44) | 0.032 |
| Duration of mechanical ventilation (in days), mean ± SD | 8.9 ± 5 | 10.7 ± 4.5 | 0.17 |
| Length of ICU stay (in days), mean ± SD | 19.7 ± 11 | 23.8 ± 13 | 0.37 |
| Lengths of hospital stay (in days), mean ± SD | 25.2 ± 10 | 24.5 ± 9 | 0.87 |
| 28-day mortality, n (%) | 9 (31) | 10 (40) | 0.49 |
SOFA sequential organ failure assessment, EVAP early ventilator-associated pneumonia, LVAP late ventilator-associated pneumonia, ICU intensive care unit